MCL-1 is one of the most widely expressed pathologic factors in human cancers,4 and many putative MCL-1 inhibitors have been synthesised, several of which have demonstrated selectivity in different types of in vitro assays.5, 6, 7, 8, 9, 10, 11, 12, 13. The gene discussed is MCL1; the disease is cancer.